CD274 and cancer: Immune checkpoints are often exploited by tumor cells as a mechanism of escape from immune surveillance, as illustrated by the overstimulation of the PD-1/PD-L1 signaling pathway, leading to reduced T cell activation and tumor-specific T cell responses in various cancers [24,25].